High Dose Rate Interstitial Brachytherapy (HDRIB) for Localized Breast Cancer: New Plan Evaluation Criteria
Byline
M Nair1 *, R Mark1 , P Anderson1 , M White1 , Y Ho1 , B Banwo1 , S Nair2 , (1) Joe Arrington Cancer Center, Lubbock, Texas, (2) Texas Tech University, Lubbock, Texas